Pembrolizumab/Enfortumab Vedotin Earns Positive CHMP Opinion in MIBC
Cancer Network,
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion…
Pembrolizumab/Enfortumab Vedotin Earns Positive CHMP Opinion in MIBC
UBM Medica,
A positive CHMP opinion supports the perioperative use of pembrolizumab plus enfortumab vedotin in resectable MIBC regardless…
EV＋ペムブロ、MIBCの補助療法として欧州で販売承認勧告を採択
Medical Tribune,
アステラス製薬は本日（9月18日）、アステラス製薬が米・ファイザーと共同開発を進めている抗体-薬物複合体エンホルツマブ ベドチン（商品名パドセブ）と、MSDの抗PD-1抗体ペムブロリズマブ（商品名キイトルーダ）との併用療法について、シスプラチンを用いた化学療…
Enfortumab vedotin plus pembrolizumab associated with improved survival in bladder cancer
2 Minute Medicine ,
1. In this phase 3 randomized controlled trial involving patients with muscle-invasive bladder cancer, perioperative enfortumab…